• 1
    Kuppers R. Molecular biology of Hodgkin's lymphoma. Adv Cancer Res 2002; 84: 277312.
  • 2
    Vassilakopoulos TP, Angelopoulou MK, Siakantaris MP, Kontopidou FN, Dimopoulou MN, Barbounis A, Grigorakis V, Karkantaris C, Anargyrou K, Chatziioannou M, Rombos J, Boussiotis VA, et al. Prognostic factors in advanced stage Hodgkin's lymphoma: the significance of the number of involved anatomic sites. Eur J Haematol 2001; 67: 27988.
  • 3
    Brice P. Prognostic factors in advanced Hodgkin's disease: can they guide therapeutic decisions? N Engl J Med 1998; 339: 15479.
  • 4
    Falzetti D, Crescenzi B, Matteuci C, Falini B, Martelli MF, Van Den Berghe H, Mecucci C. Genomic instability and recurrent breakpoints are main cytogenetic findings in Hodgkin's disease. Haematologica 1999; 84: 298305.
  • 5
    Hasse U, Tinguely M, Leibundgut EO, Cajot JF, Garvin AM, Tobler A, Borisch B, Fey MF. Clonal loss of heterozygosity in microdissected Hodgkin and Reed-Sternberg cells. J Natl Cancer Inst 1999; 91: 15813.
  • 6
    Murphy RC, Berdon WE, Ruzal-Shapiro C, Hall EJ, Kornecki A, Daneman A, Brunelle F, Campbell JB. Malignancies in pediatric patients with ataxia telangiectasia. Pediatr Radiol 1999; 29: 22530.
  • 7
    Rotman G, Shiloh Y. ATM: a mediator of multiple responses to genotoxic stress. Oncogene 1999; 18: 613544.
  • 8
    Stankovic T, Stewart GS, Byrd P, Fegan C, Moss PA, Taylor AM. ATM mutations in sporadic lymphoid tumours. Leuk Lymphoma 2002; 43: 156371.
  • 9
    Stankovic T, Byrd PJ, Cooper PR, McConville CM, Munroe DJ, Riley JH, Watts GD, Ambrose H, McGuire G, Smith AD, Sutcliffe A, Mills T, et al. Construction of a transcription map around the gene for ataxia telangiectasia: identification of at least four novel genes. Genomics 1997; 40: 26776.
  • 10
    Vanagaite L, James MR, Rotman G, Savitsky K, Bar-Shira A, Gilad S, Ziv Y, Uchenik V, Sartiel A, Collins FS. A high-density microsatellite map of the ataxia-telangiectasia locus. Hum Genet 1995; 95: 4514.
  • 11
    Gravel S, Delsol G, Al Saati T. Single-cell analysis of the t(14;18) (q32;q21) chromosomal translocation in Hodgkin's disease demonstrates the absence of this translocation in neoplastic Hodgkin and Reed-Sternberg cells. Blood 1998; 91: 286674.
  • 12
    Faumont N, Al Saati T, Brousset P, Offer C, Delsol G, Meggetto F. Demonstration by single-cell PCR that Reed-Sternberg cells and bystander B lymphocytes are infected by different Epstein-Barr virus strains in Hodgkin's disease. J Gen Virol 2001; 82: 116974.
  • 13
    Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting—Airlie House, Virginia, November, 1997. Hematol J 2000; 1: 5366.
  • 14
    Al Saati T, Galoin S, Gravel S, Lamant L, Roda D, Chittal SM, Delsol G. IgH and TcR-gamma gene rearrangements identified in Hodgkin's disease by PCR demonstrate lack of correlation between genotype, phenotype, and Epstein-Barr virus status. J Pathol 1997; 181: 38793.
  • 15
    Theriault C, Galoin S, Valmary S, Selves J, Lamant L, Roda D, Rigal-Huguet F, Brousset P, Delsol G, Al Saati T. PCR analysis of immunoglobulin heavy chain (IgH) and TcR-gamma chain gene rearrangements in the diagnosis of lymphoproliferative disorders: results of a study of 525 cases. Mod Pathol 2000; 13: 126979.
  • 16
    Camacho E, Hernandez L, Hernandez S, Tort F, Bellosillo B, Bea S, Bosch F, Montserrat E, Cardesa A, Fernandez PL, Campo E. ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances. Blood 2002; 99: 23844.
  • 17
    Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KA, Stein H, Mason DY. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984; 32: 21929.
  • 18
    Laake K, Odegard A, Andersen TI, Bukholm IK, Karesen R, Nesland JM, Ottestad L, Shiloh Y, Borresen-Dale AL. Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM. Genes Chromosomes Cancer 1997; 18: 17580.
  • 19
    Castellvi-Bel S, Sheikhavandi S, Telatar M, Tai LQ, Hwang M, Wang Z, Yang Z, Cheng R, Gatti RA. New mutations, polymorphisms, and rare variants in the ATM gene detected by a novel SSCP strategy. Hum Mutat 1999; 14: 15662.
  • 20
    Sandoval N, Platzer M, Rosenthal A, Dork T, Bendix R, Skawran B, Stuhrmann M, Wegner RD, Sperling K, Banin S, Shiloh Y, Baumer A, et al. Characterization of ATM gene mutations in 66 ataxia telangiectasia families. Hum Mol Genet 1999; 8: 6979.
  • 21
    Hauge XY, Litt M. A study of the origin of “shadow bands” seen when typing dinucleotide repeat polymorphisms by the PCR. Hum Mol Genet 1993; 2: 4115.
  • 22
    Cawkwell L, Lewis FA, Quirke P. Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction. Br J Cancer 1994; 70: 8138.
  • 23
    Gronbaek K, Worm J, Ralfkiaer E, Ahrenkiel V, Hokland P, Guldberg P. ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma. Blood 2002; 100: 14307.
  • 24
    Croce CM. Molecular biology of lymphomas. Semin Oncol 1993; 20(5 Suppl 5 ) : 3146.
  • 25
    Tilly H, Bastard C, Delastre T, Duval C, Bizet M, Lenormand B, Dauce JP, Monconduit M, Piguet H. Cytogenetic studies in untreated Hodgkin's disease. Blood 1991; 77: 1298304.
  • 26
    Haluska FG, Brufsky AM, Canellos GP. The cellular biology of the Reed-Sternberg cell. Blood 1994; 84: 100519.
  • 27
    Haidar MA, Kantarjian H, Canellos GP. ATM gene deletion in patients with adult acute lymphoblastic leukemia. Cancer 2000; 88: 105762.
  • 28
    Rosenberg MJ, Vaske D, Killoran CE, Ning Y, Wargowski D, Hudgins L, Tifft CJ, Meck J, Blancato JK, Rosenbaum K, Pauli RM, Weber J, et al. Detection of chromosomal aberrations by a whole-genome microsatellite screen. Am J Hum Genet 2000; 66: 41927.
  • 29
    Kuppers R, Rajewsky K, Zhao M, Simons G, Laumann R, Fischer R, Hansmann ML. Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci USA 1994; 91: 109626.
  • 30
    Stein H, Hummel M. Cellular origin and clonality of classic Hodgkin's lymphoma: immunophenotypic and molecular studies. Semin Hematol 1999; 36: 23341.
  • 31
    Findlay I, Ray P, Quirke P, Rutherford A, Lilford R. Allelic drop-out and preferential amplification in single cells and human blastomeres: implications for preimplantation diagnosis of sex and cystic fibrosis. Hum Reprod 1995; 10: 160918.
  • 32
    Rechitsky S, Strom C, Verlinsky O, Amet T, Ivakhnenko V, Kukharenko V, Kuliev A, Verlinsky Y. Accuracy of preimplantation diagnosis of single-gene disorders by polar body analysis of oocytes. J Assist Reprod Genet 1999; 16: 1928.
  • 33
    Garvin AM, Holzgreve W, Hahn S. Highly accurate analysis of heterozygous loci bysingle cell PCR. Nucl Acids Res 1998; 26: 346872.
  • 34
    Hahn S, Garvin AM, Di Naro E, Holzgreve W. Allele drop-out can occur in alleles differing by a single nucleotide and is not alleviated by preamplification or minor template increments. Genet Test 1998; 2: 3515.
  • 35
    Re D, Starostik P, Massoudi N, Staratschek-Jox A, Dries V, Thomas RK, Diehl V, Wolf J. Allelic losses on chromosome 6q25 in Hodgkin and Reed Sternberg cells. Cancer Res 2003; 63: 26069.
  • 36
    Liberzon E, Avigad S, Yaniv I, Stark B, Avrahami G, Goshen Y, Zaizov R. Molecular variants of the ATM gene in Hodgkin's disease in children. Br J Cancer 2004; 90: 5225.
  • 37
    Boultwood J. Ataxia telangiectasia gene mutations in leukaemia and lymphoma. J Clin Pathol 2001; 54: 5126.
  • 38
    Zhu Y, Monni O, Franssila K, Elonen E, Vilpo J, Joensuu H, Knuutila S. Deletions at 11q23 in different lymphoma subtypes. Haematologica 2000; 85: 90812.
  • 39
    Monni O, Knuutila S. 11q deletions in hematological malignancies. Leuk Lymphoma 2001; 40: 25966.
  • 40
    Cuneo A, Bigoni R, Rigolin GM, Roberti MG, Bardi A, Cavazzini F, Milani R, Minotto C, Tieghi A, Della Porta M, Agostini P, Tammiso E, et al. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders: clinico-biological significance. Haematologica 2002; 87: 4451.
  • 41
    Starczynski J, Simmons W, Flavell JR, Byrd PJ, Stewart GS, Kullar HS, Groom A, Crocker J, Moss PA, Reynolds GM, Glavina-Durdov M, Taylor AM, et al. Variations in ATM protein expression during normal lymphoid differentiation and among B-cell-derived neoplasias. Am J Pathol 2003; 163: 42332.
  • 42
    Offit K, Gilad S, Paglin S, Kolachana P, Roisman LC, Nafa K, Yeugelewitz V, Gonzales M, Robson M, McDermott D, Pierce HH, Kauff ND, et al. Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancers. Clin Cancer Res 2002; 8: 38139.
  • 43
    Takagi M, Tsuchida R, Oguchi K, Shigeta T, Nakada S, Shimizu K, Ohki M, Delia D, Chessa L, Taya Y, Nakanishi M, Tsunematsu Y, et al. Identification and characterization of polymorphic variations of the ataxia telangiectasia mutated (ATM) gene in childhood Hodgkin disease. Blood 2004; 103: 28390.
  • 44
    Schaffner C, Stilgenbauer S, Rappold GA, Dohner H, Lichter P. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia. Blood 1999; 94: 74853.
  • 45
    Teraoka SN, Telatar M, Becker-Catania S, Liang T, Onengut S, Tolun A, Chessa L, Sanal O, Bernatowska E, Gatti RA, Concannon P. Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences. Am J Hum Genet 1999; 64: 161731.
  • 46
    Eng L, Coutinho G, Nahas S, Yeo G, Tanouye R, Babaei M, Dork T, Burge C, Gatti RA. Nonclassical splicing mutations in the coding and noncoding regions of the ATM gene: maximum entropy estimates of splice junction strengths. Hum Mutat 2004; 23: 6776.
  • 47
    Becker-Catania SG, Chen G, Hwang MJ, Wang Z, Sun X, Sanal O, Bernatowska-Matuszkiewicz E, Chessa L, Lee EY, Gatti RA. Ataxia-telangiectasia: phenotype/genotype studies of ATM protein expression, mutations, and radiosensitivity. Mol Genet Metab 2000; 70: 12233.
  • 48
    Benharouga M, Haardt M, Kartner N, Lukacs GL. COOH-terminal truncations promote proteasome-dependent degradation of mature cystic fibrosis transmembrane conductance regulator from post-Golgi compartments. J Cell Biol 2001; 153: 95770.
  • 49
    Wagner E, Lykke-Andersen J. mRNA surveillance: the perfect persist. J Cell Sci 2002; 115: 30338.